孤立肾上尿路尿路上皮癌的内镜下保肾手术:肿瘤控制、肾功能与透析风险
这项多中心回顾性队列研究纳入62例孤立肾上尿路尿路上皮癌患者,2006至2024年间接受以输尿管镜活检与激光消融为主的内镜下保肾手术(eKSS)并强化监测。中位随访65个月,5年上尿路复发累积发生率70%、进展40%、癌症特异性死亡率20%、透析依赖32%;基线eGFR<30者透析风险显著升高(HR 5.68)。eKSS在强化监测下可持久保留肾功能,肿瘤学结局可接受。
要点
- 孤立肾UTUC行eKSS后5年复发累积发生率70%,需反复输尿管镜干预。
- 5年癌症特异性死亡20%、进展40%,肿瘤学结局在强制保肾情境下可接受。
- 5年透析依赖32%,基线eGFR<30者风险显著升高(HR 5.68)。
核心结论
- 在孤立肾UTUC患者中,于强化监测方案内实施eKSS可实现持久的肾功能保留,肿瘤学结局可接受。
- 尽管复发频繁且需反复输尿管镜干预,癌症特异性死亡率仍有限,支持eKSS作为强制临床情境下根治性肾输尿管切除术的可行替代。
研究设计与样本
- 回顾性多中心队列研究,纳入2006至2024年两家三级转诊中心连续62例孤立肾UTUC并接受初次eKSS的患者。
- 所有患者接受输尿管镜活检与激光消融,随后强化监测,包括强制二次输尿管镜检及按需重复治疗。
- 主要终点为上尿路复发、进展、癌症特异性死亡和透析依赖,采用竞争风险累积发生率函数与线性混合效应模型分析。
主要发现
- 中位年龄71岁(IQR 67-77),基线eGFR 48 mL/min/1.73 m2(IQR 40-70),初始输尿管镜高级别病变12例(19%)。
- 中位随访65个月,中位输尿管镜次数5次(IQR 3-9),16例(26%)最终接受根治性肾输尿管切除术。
- 5年上尿路复发累积发生率70%(95%CI 58-83),5年进展累积发生率40%(95%CI 26-54)。
- 5年癌症特异性死亡率20%(95%CI 7.9-32),5年透析依赖率32%(95%CI 18-45)。
- 基线eGFR<30 mL/min/1.73 m2者透析依赖风险升高(HR 5.68;95%CI 1.20-27.0,P=0.029),混合效应模型示eGFR年均下降2.9 mL/min/1.73 m2(95%CI 1.2-4.6)。
临床怎么用
- 对孤立肾UTUC患者,eKSS可作为强制保肾情境下的可选方案,但须配套强制二次输尿管镜检与密集随访。
- 基线eGFR<30 mL/min/1.73 m2者透析风险显著升高,术前应充分告知并个体化决策。
局限性
- 回顾性多中心设计,样本量62例,可能存在选择偏倚与中心间异质性。
- 原文未报告对照组,无法直接比较eKSS与根治性肾输尿管切除术的疗效差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate cancer control, renal function trajectories, and dialysis risk in patients with a solitary kidney treated with endoscopic kidney-sparing surgery (eKSS) for upper tract urothelial carcinoma (UTUC). PATIENTS AND METHODS: We conducted a retrospective multicentre cohort study including 62 consecutive patients with UTUC and a solitary kidney treated with primary eKSS between 2006 and 2024 at two tertiary referral centres. All patients underwent ureteroscopic biopsy and laser ablation followed by intensified surveillance with mandatory second-look ureteroscopy and repeat retreatment as needed. Primary endpoints were upper tract recurrence, progression, cancer-specific mortality, and dialysis dependency. Competing-risk cumulative incidence functions and linear mixed-effects models were used. RESULTS: Median age was 71 years (interquartile range [IQR] 67-77), and baseline estimated glomerular filtration rate (eGFR) was 48 mL/min/1.73 m2 (IQR 40-70). High-grade disease at initial ureteroscopy was present in 12 patients (19%). Over a median follow-up of 65 months, patients underwent a median of five ureteroscopies (IQR 3-9), and 16 (26%) ultimately underwent radical nephroureterectomy. The cumulative incidence of upper tract recurrence was 70% (95% confidence interval [CI] 58-83) at 5 years. The 5-year cumulative incidence of progression was 40% (95% CI 26-54). Cancer-specific mortality was 20% (95% CI 7.9-32) at 5 years. Dialysis dependency occurred in 32% (95% CI 18-45) at 5 years, predominantly among patients with baseline eGFR <30 mL/min/1.73 m2 (hazard ratio 5.68; 95% CI 1.20-27.0, P = 0.029). Mixed-effects modelling showed a mean annual eGFR decline of 2.9 mL/min/1.73 m2 (95% CI 1.2-4.6). CONCLUSIONS: In patients with UTUC and a solitary kidney, eKSS delivered within an intensive surveillance programme provided durable renal preservation with acceptable oncological outcomes. Despite frequent recurrences requiring repeated ureteroscopic interventions, cancer-specific mortality remained limited, supporting eKSS as a viable alternative to radical nephroureterectomy in imperative clinical settings.
引用
- Scilipoti P, Zorzi F, Gonzalez CG, et al. Endoscopic kidney-sparing surgery for upper tract urothelial carcinoma in patients with a solitary kidney. BJU Int. 2026. PMID: 42749682. doi:10.1111/bju.70454
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。